Omega 3 Supplements
Introduction
Omega-3 fatty acids (omega-3s)
are a group of polyunsaturated fatty acids that are important for a
number of functions in the body. Some types of omega-3s are found in
foods such as fatty fish and shellfish. Another type is found in some
vegetable oils. Omega-3s are also available as dietary supplements.
This fact sheet provides basic information about omega-3s—with a focus
on dietary supplements, summarizes scientific research on effectiveness
and safety, and suggests sources for additional information.
Key Facts
There
has been a substantial amount of research on supplements of omega-3s,
particularly those found in seafood and fish oil, and heart disease.
The findings of individual studies have been inconsistent. In 2012, two
combined analyses of the results of these studies did not find
convincing evidence these omega-3s protect against
heart disease.
There
is some evidence that omega-3s found in seafood and fish oil may be
modestly helpful in relieving symptoms in rheumatoid arthritis. For
most other conditions for which omega-3s have been studied, definitive
conclusions cannot yet be reached, or studies have not shown omega-3s
to be beneficial.
Omega-3 supplements may interact with drugs that affect
blood clotting.
It is uncertain whether people with fish or shellfish allergies can
safely consume fish oil supplements.
Fish
liver oils (which are not the same as fish oils) contain vitamins A and
D as well as omega-3 fatty acids; these vitamins can be toxic in
high doses.
Tell all your health care providers about any
complementary health approaches you use. Give them a full picture of
what you do to manage your health. This will help ensure coordinated
and safe care.
About Omega-3 Fatty Acids
The
three principal omega-3 fatty acids are alpha-linolenic acid (ALA),
eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). The main
sources of ALA in the U.S. diet are vegetable oils, particularly canola
and soybean oils; flaxseed oil is richer in ALA than soybean and canola
oils but is not commonly consumed. ALA can be converted, usually in
small amounts, into EPA and DHA in the body. EPA and DHA are found in
seafood, including fatty fish (e.g., salmon, tuna, and trout) and
shellfish (e.g., crab, mussels, and oysters).
Commonly
used dietary supplements that contain omega-3s include fish oil (which
provides EPA and DHA) and flaxseed oil (which provides ALA). Algae oils
are a vegetarian source of DHA.
Omega-3
fatty acids are important for a number of bodily functions, including
muscle activity, blood clotting, digestion, fertility, and cell
division and growth. DHA is important for brain development and
function. ALA is an “essential” fatty acid, meaning that people must
obtain it from food or supplements because the human body cannot
manufacture it.
Safety
Omega-3 fatty acid supplements
usually do not have negative side effects. When side effects do occur,
they typically consist of minor gastrointestinal symptoms, such as
belching, indigestion, or diarrhea.
It is uncertain whether people with fish or shellfish allergies can
safely consume fish oil supplements.
Omega-3
supplements may extend bleeding time (the time it takes for a cut to
stop bleeding). People who take drugs that affect bleeding time, such
as anticoagulants (“blood thinners”) or nonsteroidal anti-inflammatory
drugs (NSAIDs), should discuss the use of omega-3 fatty acid
supplements with a health care provider.
Fish liver oils, such
as cod liver oil, are not the same as fish oil. Fish liver oils contain
vitamins A and D as well as omega-3 fatty acids. Both of these vitamins
can be toxic in large doses. The amounts of vitamins in fish liver oil
supplements vary from one product to another.
There is
conflicting evidence about whether omega-3 fatty acids found in seafood
and fish oil might increase the risk of prostate cancer. Additional
research on the association of omega-3 consumption and prostate cancer
risk is under way.
Use of Omega-3 Supplements in the United States
According
to the 2012 National Health Interview Survey, which included a
comprehensive survey on the use of complementary health approaches in
the United States, fish oil supplements are the nonvitamin/nonmineral
natural product most commonly taken by both adults and children. The
survey findings indicated that about 7.8 percent of adults (18.8
million) and 1.1 percent of children age 4 to 17 (664,000) had taken a
fish oil supplement in the previous 30 days.
What the Science Says
Moderate
evidence has emerged about the health benefits of eating seafood. The
health benefits of omega-3 dietary supplements are unclear.
Cardiovascular Disease
Evidence
suggests that seafood rich in omega-3 fatty acids should be included in
a heart-healthy diet. However, omega-3s in supplement form have not
been shown to protect against heart disease.
Epidemiological
studies done more than 30 years ago noted relatively low death rates
due to cardiovascular disease in Eskimo populations with high seafood
consumption. Since then, much research has been done on seafood and
heart disease. The results provide moderate evidence that people who
eat seafood at least once a week are less likely to die of heart
disease than those who rarely or never eat seafood.
The Federal Government’s
Dietary Guidelines for
Americans, 2010 includes
a new recommendation that adults eat 8 or more ounces of a variety of
seafood (fish or shellfish) per week because it provides a range of
nutrients, including omega-3 fatty acids. (Smaller amounts are
recommended for young children.)
Many studies have evaluated the effects of supplements rich in EPA and
DHA, such as fish oil, on heart disease risk.
In
these studies, researchers compared the number of cardiovascular events
(such as heart attacks or strokes) or the number of deaths in people
who were given the supplements with those in people who were given
inactive substances (placebos) or standard care. Most of these studies
involved people who already had evidence of heart disease. A smaller
number of studies included people with no history of
heart disease.
The
results of individual studies were inconsistent; some indicated that
the supplements were protective, but others did not.
In 2012,
two groups of scientists conducted meta-analyses of these studies; one
group analyzed only studies in people with a history of heart disease,
and the other group analyzed studies in people both with and without a
history of heart disease. Neither meta-analysis found convincing
evidence of a protective effect.
In 2014, researchers examined
the results of the newest high-quality studies of omega-3s, all of
which were completed in 2005 or later. Of nine studies that examined
the effects of omega-3s on outcomes related to heart disease, such as
heart attacks or abnormal heart rhythms, only one found evidence of a
beneficial effect.
There are several reasons why supplements
that contain EPA and DHA may not help to prevent heart disease even
though a diet rich in seafood may. Eating seafood a few times a week
might provide enough of these omega-3s to protect the heart; more may
not be better. Some of the benefits of seafood may result from people
eating it in place of less healthful foods. There is also evidence that
people who eat seafood have generally healthier lifestyles, and these
other lifestyle characteristics may be responsible for the lower
incidence of cardiovascular disease.
Rheumatoid Arthritis
A
2012 systematic review concluded that the types of omega-3s found in
seafood and fish oil may be modestly helpful in relieving symptoms of
rheumatoid arthritis. In the studies included in the review, many of
the participants reported that when they were taking fish oil they had
briefer morning stiffness, less joint swelling and pain, and less need
for anti-inflammatory drugs to control their symptoms.
Infant Development
The
nutritional value of seafood is particularly important during early
development. The 2010 Dietary Guidelines recommend that women who are
pregnant or breastfeeding consume at least 8 ounces but no more than 12
ounces of seafood each week and not eat certain types of seafood that
are high in mercury—a toxin that can harm the nervous system of a fetus
or young child.
For
more information on seafood consumption for women who are pregnant or
breastfeeding, see MyPlate.gov.
Diseases
of the Brain and the Eye
DHA
plays important roles in the functioning of the brain and the eye.
Research is being conducted on DHA and other omega-3 fatty acids and
diseases of the brain and eye, but there is not enough evidence to draw
conclusions about the effectiveness of omega-3s for
these conditions.
Research
is looking at:
Diseases
of the eye, such as age-related macular degeneration (AMD; an eye
disease that can cause vision loss in older people) and dry eye
syndrome. Studies have shown that people who eat diets rich in seafood
are less likely to develop the advanced stage of AMD. However, a large
National Institutes of Health (NIH)–sponsored study, called Age-Related
Eye Disease Study 2 (AREDS2), indicated that supplements containing EPA
and DHA did not slow the progression of AMD in people who were at high
risk of developing the advanced stage of this disease.
Diseases
of the brain or nervous system, such as cognitive decline and multiple
sclerosis. Study results published in 2015 indicated that taking EPA
and DHA supplements did not slow cognitive decline in older adults. The
people who were studied were participants in AREDS2, and therefore all
of them had the eye disease AMD.
Mental and behavioral health
problems, such as depression, attention-deficit hyperactivity disorder,
autism, bipolar disorder, borderline personality disorder,
and schizophrenia.
Other Conditions
Omega-3
supplements (primarily fish oil supplements) also have been studied for
preventing or treating a variety of other conditions such as allergies,
asthma, cachexia (severe weight loss) associated with advanced cancer,
Crohn's disease, cystic fibrosis, diabetes, kidney disease, lupus,
menstrual cramps, obesity, osteoporosis, and ulcerative colitis, as
well as organ transplantation outcomes (e.g., decreasing the likelihood
of rejection). No conclusions can be drawn about whether omega-3s are
helpful for these conditions based on currently
available evidence.
If You Are Considering Omega-3 Supplements
Do
not use omega-3 supplements to replace conventional care or to postpone
seeing a health care provider about a health problem.
Consult
your health care provider before using omega-3 supplements. If you are
pregnant, trying to become pregnant, or breastfeeding; if you take
medicine that affects blood clotting; if you are allergic to fish or
shellfish; or if you are considering giving a child an omega-3
supplement, it is especially important to consult your (or your
child's) health care provider.
Look for published research studies on omega-3 supplements for the
health condition that interests you. Information on
evidence-based
studies is
available from NCCIH.
Tell
all your health care providers about any complementary health
approaches you use. Give them a full picture of what you do to manage
your health. This will help ensure coordinated and safe care.
NCCIH-Funded Research
Recent
NCCIH-sponsored studies have been investigating the effects of
omega-3s/fish oil on conditions including:
Adolescent depression
Autism spectrum disorders
Brain injury
Complications of HIV infection, including bone loss
Depression during pregnancy and postpartum depression
Treatment-resistant epilepsy
Other
NIH research includes studies on the effects of omega-3s/fish oil on
many different conditions, including:
Autoimmune diseases
Alzheimer's disease
Diabetic kidney disease
Pregnancy outcome, including infant health and development
Sudden cardiac death
Key References
- Age-Related
Eye Disease Study 2 (AREDS2) research group. Lutein
+ zeaxanthin and omega-3 fatty acids for age-related macular
degeneration. The Age-Related Eye Disease Study 2 (AREDS2)
randomized clinical trial. JAMA. 2013;309(19):2005–2015.
- Anandan
C, Nurmatov U, Sheikh A. Omega
3 and 6 oils for primary prevention of allergic disease: systematic
review and meta-analysis.Allergy. 2009;64(6):840–848.
- Appleton
KM, Rogers PJ, Ness AR. Updated
systematic review and meta-analysis of the effects of n-3 long-chain
polyunsaturated fatty acids on depressed mood. American Journal of Clinical
Nutrition. 2010;91(3):757–770.
- Bent
S, Bertoglio K, Hendren RL. Omega-3
fatty acids for autistic spectrum disorder: a systematic review. Journal of Autism and
Developmental Disorders. 2009;39(8):1145–1154.
- Black
LI, Clarke TC, Barnes PM, Stussman BJ, Nahin RL. Use
of complementary health approaches among children aged 4‒17 years in
the United States: National Health Interview Survey, 2007‒2012.
[300K <a href=”#pdf”>PDF</a>] National
health statistics
reports; no 78. Hyattsville, MD: National Center for Health
Statistics. 2015.
- Brasky
TM, Till C, White E, et al. Serum
phospholipid fatty acids and prostate cancer risk: results from the
prostate cancer prevention trial. American Journal of Epidemiology. 2011;173(12):1429–1439.
- Buckley
JD, Howe PR. Anti-obesity
effects of long-chain omega-3 polyunsaturated fatty acids. Obesity Reviews. 2009;10(6):648–659.
- Calder
PC, Yaqoob P. Omega-3
polyunsaturated fatty acids and human health outcomes. Biofactors. 2009;35(3):266–272.
- Chew
EY, Clemons TE, Agron E, et al. Effect
of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient
supplementation on cognitive function. The AREDS2
randomized clinical trial. JAMA. 2015;314(8):791-801.
- Chong
EW-T, Kreis AJ, Wong TY, et al. Dietary
omega-3 fatty acid and fish intake in the primary prevention of
age-related macular degeneration. A
systematic review and meta-analysis. Archives of Ophthalmology. 2008;126(6):826–833.
- Clarke
TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends
in the use of complementary health approaches among adults: United
States, 2002–2012 [240K
<a href=”#pdf”>PDF</a>]. National health
statistics
reports; no 79. Hyattsville, MD: National Center for Health
Statistics. 2015.
- Covington
MB. Omega-3
fatty acids. American Family Physician. 2004;70(1):133–140.
- De
Ley M, de Vos R, Hommes DW, et al. Fish
oil for induction of remission in ulcerative colitis. Cochrane Database of Systematic
Reviews. 2007;(4):CD005986
[edited 2008]. Accessed at www.thecochranelibrary.com(link
is external) on
November 2, 2012.
- Farinotti
M, Simi S, Di Pietrantonj C, et al. Dietary interventions for multiple
sclerosis. Cochrane Database of Systematic
Reviews. 2007;(1):CD004192
[edited 2009]. Accessed at www.thecochranelibrary.com(link
is external) on
November 2, 2012.
- Fassett
RG, Gobe GC, Peake JM, et al. Omega-3
polyunsaturated fatty acids in the treatment of kidney disease. American Journal of Kidney
Diseases. 2010;56(4):728–742.
- Filion
KB, El Khoury F, Bielinski M, et al. Omega-3
fatty acids in high-risk cardiovascular patients: a meta-analysis of
randomized controlled trials.BMC Cardiovascular Disorders. 2010;10:24.
- Grey
A, Bolland M. Clinical
trial evidence and use of fish oil supplements. JAMA Internal Medicine. 2014;174(3):460-462.
- Hooper
L, Harrison RA, Summerbell CD, et al. Omega
3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic
Reviews. 2004;(4):CD003177
[edited 2009]. Accessed at www.thecochranelibrary.com(link
is external) on
November 2, 2012.
- Hu
FB, Manson JE. Omega-3
fatty acids and secondary prevention of cardiovascular disease—is it
just a fish tale? Archives of Internal Medicine. 2012;172(9):694–696.
- Huang
TL. Omega-3
fatty acids, cognitive decline, and Alzheimer’s disease: a critical
review and evaluation of the literature. Journal of Alzheimer’s Disease. 2010;21(3):673–690.
- Irving
CB, Mumby-Croft R, Joy LA. Polyunsaturated
fatty acid supplementation for schizophrenia. Cochrane Database of Systematic
Reviews. 2006;(3):CD001257
[edited 2010]. Accessed at www.thecochranelibrary.com(link
is external) on
November 2, 2012.
- Kris-Etherton
PM, Harris WS, Appel LJ, et al. Fish
consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747–2757.
- Kwak
SM, Myung S-K, Lee YJ, et al. Efficacy
of omega-3 fatty acid supplements (eicosapentaenoic acid and
docosahexaenoic acid) in the secondary prevention of cardiovascular
disease. A meta-analysis of randomized, double-blind,
placebo-controlled trials. Archives of Internal Medicine. 2012;172(9):686–694.
- Lee
JH, O’Keefe JH, Lavie CJ, et al. Omega-3
fatty acids: cardiovascular benefits, sources and sustainability. Nature Reviews. Cardiology. 2009;6(12):753–758.
- Miles
EA, Calder PC. Influence
of marine n-3 polyunsaturated fatty acids on immune function and a
systematic review of their effects on clinical outcomes in rheumatoid
arthritis. British Journal of Nutrition. 2012;107(Suppl 2):S171–S184.
- Oh
R. Practical
applications of fish oil (omega-3 fatty acids) in primary care.Journal of the American Board of
Family Practice. 2005;18(1):28–36.
- Oliver
C, Everard M, N’Diaye T. Omega-3 fatty acids (from fish oils) for
cystic fibrosis. Cochrane Database of Systematic
Reviews. 2007;(4):CD002201
[edited 2010]. Accessed at www.thecochranelibrary.com(link
is external) on
November 2, 2012.
- Raz
R, Gabis L. Essential
fatty acids and attention-deficit-hyperactivity disorder: a systematic
review. Developmental Medicine and Child
Neurology. 2009;51(8):580–592.
- Riediger
ND, Othman RA, Suh M, et al. A
systemic review of the roles of n-3 fatty acids in health and disease. Journal of the American Dietetic
Association. 2009;109(4):668–679.
- Rizos
EC, Ntzani EE, Bika E, et al. Association
between omega-3 fatty acid supplementation and risk of major
cardiovascular disease events. A systematic review and meta-analysis. JAMA. 2012;308(10):1024–1033.
- Salari
P, Rezaie A, Larijani B, et al. A
systematic review of the impact of n-3 fatty acids in bone health and
osteoporosis. Medical Science Monitor. 2008;14(3):RA37–44.
- Saravanan
P, Davidson NC, Schmidt EB, et al. Cardiovascular
effects of marine omega-3 fatty acids. Lancet.
2010;376 (9740):540–550.
- Szymanski
KM, Wheeler DC, Mucci LA. Fish
consumption and prostate cancer risk: a review and meta-analysis. American Journal of Clinical
Nutrition. 2010;92(5):1223–1233.
- Turner
D, Zlotkin SH, Shah PS, et al. Omega
3 fatty acids (fish oil) for maintenance of remission in Crohn’s
disease. Cochrane Database of Systematic
Reviews. 2009;(1):CD006320.
Accessed at www.thecochranelibrary.com(link
is external) on
November 2, 2012.
- Weitz
D, Weintraub H, Fisher E, et al. Fish
oil for the treatment of cardiovascular disease. Cardiology in Review. 2010;18(5):258–263.
-NIH